Cargando…

Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders

BACKGROUND: Inflammatory processes could underlie mood disorders. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMP) are inflammation-related molecules. The current study sought an association between mood disorders and systemic levels of MMPs and TIMPs. METHODS: Serum was obtaine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shibasaki, Chiyo, Takebayashi, Minoru, Itagaki, Kei, Abe, Hiromi, Kajitani, Naoto, Okada-Tsuchioka, Mami, Yamawaki, Shigeto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043640/ https://www.ncbi.nlm.nih.gov/pubmed/26912606 http://dx.doi.org/10.1093/ijnp/pyw019

Ejemplares similares

PS159. Altered serum levels of matrix metalloproteinase-2, -9 in response to electroconvulsive therapy for mood disorders.
por: Shibasaki, Chiyo, et al.
Publicado: (2016)

Possible Association between Serum Matrix Metalloproteinase-9 (MMP-9) Levels and Relapse in Depressed Patients following Electroconvulsive Therapy (ECT)
por: Shibasaki, Chiyo, et al.
Publicado: (2017)

PS127. Antidepressant amitriptyline activates matrix metalloproteinase in astroglial cells: involvement in glial cell line-derived neurotrophic factor expression.
por: Abe, Hiromi, et al.
Publicado: (2016)

Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy
por: Abe, Hiromi, et al.
Publicado: (2023)

Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder
por: Itagaki, Kei, et al.
Publicado: (2019)

Shared preventive factors associated with relapse after a response to electroconvulsive therapy in four major psychiatric disorders
por: Omori, Wataru, et al.
Publicado: (2019)

Decreased serum levels of thrombospondin‐1 in female depressed patients
por: Okada‐Tsuchioka, Mami, et al.
Publicado: (2019)

PS158. Factors associated with relapse after a response to electroconvulsive therapy in unipolar versus bipolar depression
por: Itagake, Kei, et al.
Publicado: (2016)

Antidepressant amitriptyline‐induced matrix metalloproteinase‐9 activation is mediated by Src family tyrosine kinase, which leads to glial cell line‐derived neurotrophic factor mRNA expression in rat astroglial cells
por: Abe, Hiromi, et al.
Publicado: (2019)

Factors associated with the risk of relapse in schizophrenic patients after a response to electroconvulsive therapy: a retrospective study
por: Shibasaki, Chiyo, et al.
Publicado: (2015)

Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2020)

Antidepressant Acts on Astrocytes Leading to an Increase in the Expression of Neurotrophic/Growth Factors: Differential Regulation of FGF-2 by Noradrenaline
por: Kajitani, Naoto, et al.
Publicado: (2012)

Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2021)

PM324. Case study on alcohol withdrawal with transient periodic synchronous discharge
por: Komo, Kenji, et al.
Publicado: (2016)

Treating electroconvulsive therapy–induced mania with more electroconvulsive therapy: Evidence for electroconvulsive therapy as the ultra-mood stabilizer
por: Thomas, Rejish K, et al.
Publicado: (2018)

Neural Functions of Matrix Metalloproteinases: Plasticity, Neurogenesis, and Disease
por: Fujioka, Hiromi, et al.
Publicado: (2012)

Age‐related white matter changes revealed by a whole‐brain fiber‐tracking method in bipolar disorder compared to major depressive disorder and healthy controls
por: Masuda, Yoshikazu, et al.
Publicado: (2020)

White matter abnormalities and cognitive function in euthymic patients with bipolar disorder and major depressive disorder
por: Masuda, Yoshikazu, et al.
Publicado: (2020)

Matrix Metalloproteinases in Human Decidualized Endometrial Stromal Cells
por: Hisamatsu, Yoji, et al.
Publicado: (2021)

Importance of the Habenula for Avoidance Learning Including Contextual Cues in the Human Brain: A Preliminary fMRI Study
por: Yoshino, Atsuo, et al.
Publicado: (2020)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Important role of matrix metalloproteinase 9 in epileptogenesis
por: Wilczynski, Grzegorz M., et al.
Publicado: (2008)

Expression of Matrix Metalloproteinase-9 in Gastric Cancer
por: R, Prathipaa, et al.
Publicado: (2021)

Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
por: Wei, Ting, et al.
Publicado: (2016)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
por: Erabi, Hisayuki, et al.
Publicado: (2020)

Rocuronium-sugammadex use for electroconvulsive therapy in a hemodialysis patient: a case report
por: Kurita, Shigeaki, et al.
Publicado: (2016)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023)

Expression and Significance of Matrix Metalloproteinase-2 and Matrix Metalloproteinas-9 in Endometriosis
por: Barbe, Adrian Mykhailovych, et al.
Publicado: (2020)

Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke
por: Manso, Helena, et al.
Publicado: (2010)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
por: Liu, Chuan Ze, et al.
Publicado: (2022)

Production of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Breast Carcinomas
por: Iwata, Hiroji, et al.
Publicado: (1996)

A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities
por: ZHANG, HONGQI, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e9s3k8qsdmvne4cgi9mb46ktd4